Found 0 matching trials
A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP PHASE1 This is an open label, multicenter, dose escalation, phase Ib study to dete...
Show More Location
Institut Jules Bordet
Learn More & Join Trial
Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis PHASE1 This is a patient-sponsored study that evaluates the safety and efficacy of...
Show More Location
Makati Medical Center
Learn More & Join Trial
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial PHASE4 This study aims to determine whether the recurrence rate of high-risk acute...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Cancer Center and Beckman Research Institute, City of Hope
Learn More & Join Trial
ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma PHASE1 Open-labeled, multicenter, phase I/II study of imatinib combined with ESHAP...
Show More Location
Dong-A University Hospital
Learn More & Join Trial
A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL NA This project is a key clinical research project approved by the Clinical Re...
Show More Location
First Affiliated Hospital of Xian Jiaotong University
Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia PHASE2 This is a phase 2 single-arm, open-label clinical trial determining efficac...
Show More Status
Active Not Recruiting
Location
University of California, Los Angeles
Learn More & Join Trial
High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML PHASE2 The purpose of this study is to determine the effectiveness of a particular...
Show More Location
The University of Chicago
Learn More & Join Trial
Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia PHASE2 RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Show More Location
Naval Medical Center - San Diego
Learn More & Join Trial